PDS Biotechnology updates corporate presentation deck; no material new disclosures

PDS Biotechnology Corp

Filed corporate presentation dated February 2026 under Item 8.01.
Presentation title: 'Precision Designed Science for Cancer Patients'.
No specific clinical, financial, or strategic updates provided in the filing.
Confidence is low as only the title slide of the deck is visible.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.